Influenza Hemagglutinin (HA) Peptide: Precision Epitope Tag for Protein Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic nine-amino acid tag derived from the influenza virus hemagglutinin protein and is used for detection, purification, and interaction studies in molecular biology [APExBIO]. HA tag peptides exhibit high solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL) under laboratory conditions, ensuring compatibility with varied assay formats. The tag binds competitively to Anti-HA antibodies, enabling efficient elution of HA-tagged proteins in immunoprecipitation workflows [Wei et al., 2021]. APExBIO's A6004 kit guarantees >98% purity as confirmed by HPLC and mass spectrometry, supporting reproducible results. These properties make the HA tag a gold standard for epitope tagging in protein-protein interaction and exosome research [GDC-0449.com].

Biological Rationale

The Influenza Hemagglutinin (HA) Peptide is derived from the human influenza virus hemagglutinin protein's epitope region. The consensus sequence, YPYDVPDYA, is not present in higher eukaryotic proteomes, minimizing non-specific background in detection assays (Wei et al., 2021). This unique sequence enables it to serve as a universal molecular tag for recombinant proteins expressed in diverse host systems, including mammalian, yeast, and insect cells [Magnetic-Co-IP]. HA-tagged constructs allow for straightforward immunodetection and affinity purification using Anti-HA antibodies. The tag's small size minimizes steric hindrance, preserving the function of the fusion protein in most contexts. This reduces the risk of altered protein localization or function, a common limitation of bulkier tags.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA tag peptide acts as an epitope recognized with high affinity and specificity by Anti-HA monoclonal antibodies (e.g., clone 12CA5). In immunoprecipitation, HA-tagged proteins are captured on Anti-HA antibody-conjugated solid supports. When the synthetic HA peptide is added in excess, it competitively binds to the antibody, displacing the HA-tagged protein and enabling its elution in a functional, non-denatured state. This competitive elution mechanism is critical for preserving native protein complexes and is widely used in co-immunoprecipitation and exosome pathway research (Wei et al., 2021). The high solubility of the peptide ensures efficient interaction with antibodies across a range of buffer conditions. The tag is also compatible with downstream detection methods such as Western blotting, ELISA, and mass spectrometry.

Evidence & Benchmarks

• HA-tag immunoprecipitation enables the isolation of low-abundance protein complexes from mammalian cell lysates with minimal background, as demonstrated in exosome pathway research (Wei et al. 2021, DOI).
• The HA tag peptide (sequence YPYDVPDYA) exhibits no endogenous cross-reactivity in human or mouse cell lines, confirmed by negative controls in immunoprecipitation and Western blotting (Wei et al. 2021, DOI).
• Competitive elution of HA-tagged proteins with synthetic HA peptide preserves protein-protein interactions and post-translational modifications (Wei et al. 2021, DOI).
• APExBIO's A6004 HA peptide achieves >98% purity by HPLC and mass spectrometry, supporting reproducibility in quantitative proteomics (APExBIO).
• Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water at room temperature (APExBIO).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is employed for:

• Affinity purification of HA-tagged recombinant proteins from cell lysates.
• Protein-protein interaction studies via co-immunoprecipitation.
• Elution of HA-tagged proteins from Anti-HA Magnetic Beads or antibody resins.
• Epitope tagging for detection in Western blot, immunofluorescence, and ELISA.
• Exosome pathway research for tracking tagged cargo proteins [GDC-0449.com].

This article extends prior discussions by providing detailed solubility, purity, and competitive binding data, building on mechanistic overviews found in "Transforming Epitope Tag Workflows" and updating strategic guidance from "Translational Power Unleashed" with new evidence on post-translational modification preservation.

Common Pitfalls or Misconceptions

• The HA tag does not universally avoid all steric hindrance; N- or C-terminal fusion may disrupt folding of sensitive proteins.
• HA peptide competitive elution cannot dissociate highly stable or covalent protein complexes.
• Not suitable for in vivo tracking unless the fusion protein is expressed in target tissue; endogenous HA protein is absent in mammalian systems.
• Long-term storage of HA peptide solutions can result in degradation; only store desiccated powder at -20°C.
• High concentrations of denaturants in buffers may reduce antibody-epitope affinity and efficiency of elution.

Workflow Integration & Parameters

The Influenza Hemagglutinin (HA) Peptide (A6004) from APExBIO integrates into standard immunoprecipitation and protein purification workflows. For competitive elution, use a final concentration of 1–2 mg/mL HA peptide in elution buffer. The peptide dissolves efficiently in DMSO, ethanol, or water, allowing rapid buffer preparation. Maintain samples at 4°C during use; avoid repeated freeze-thaw cycles. Store lyophilized peptide desiccated at -20°C for long-term stability. The peptide is validated for use with Anti-HA Magnetic Beads and conventional Anti-HA monoclonal antibodies. Quantitative elution efficiency is achieved within 30–60 minutes at room temperature in standard PBS or Tris-HCl buffers (pH 7.4–7.5). For best results, avoid high concentrations of reducing agents or strong detergents in elution buffer.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide is an essential tool for modern molecular biology, enabling precise, reproducible detection and purification of HA-tagged proteins. Its atomic specificity, high solubility, and compatibility with competitive elution protocols distinguish it from alternative tags. APExBIO's A6004 product assures high purity and batch-to-batch consistency. As research in exosome pathways and protein complex biology advances, the HA tag remains a gold standard for epitope tagging, with ongoing improvements in antibody and resin technologies expected to further enhance its utility. For additional mechanistic insights and strategic guidance, see "Advanced Strategies for HA Peptide Applications".